Bristol Myers Squibb (BMY) Q2 2026 (USD): Adj. EPS 2.04 (exp. 1.59), Revenue 12.97bln (exp. 11.75bln)

SourceNewsquawk
SectionUS Equities

Outlook

  • FY revenue about 49-50bln (exp. 47.47bln).
  • FY adj. EPS 6.75-7.00 (exp. 6.34).
Published: Updated:

Free. No signup, no card.

Use the Platform